Trademark Overview
On Wednesday, April 30, 2025, a trademark application was filed for NEURASPEECH with the United States Patent and Trademark Office. The USPTO has given the NEURASPEECH trademark a serial number of 99163527. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, September 19, 2025. This trademark is owned by NeuraSpeech Technologies. The NEURASPEECH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Online non-downloadable Software as a Service (SaaS) software for managing, administering and tracking speech-language pathology therapy outcomes; SaaS tools for healthcare practice management, clinical documentation, and assessments for speech therapy, audiology, and other healthcare professionals; Platform as a Service (PaaS) offering modular software tools for integration into digital healthcare marketplaces; SaaS solutions for healthcare data management, clinical evaluations, and regulatory compliance support; Design, development, and maintenance of enterprise and customized healthcare software using AI, blockchain, and virtual environments; Application Service Provider (ASP) services automating healthcare workflows and patient documentation; Software development and consultancy services supporting regulatory, diagnostic, and therapeutic functions in speech-language pathology, audiology, and related healthcare fields
